Neuroendocrine Cancer UK is excited to announce the newest episode in our Not Just NE Cancer Takeover Podcast Series. This episode delves into the realm of research, featuring an interview with Andy Hall, the Chief Scientific Officer at RareCan – an organisation dedicated to improving outcomes for individuals battling rare forms of cancer.
Andy shares his journey from a lab-based researcher specialising in pediatric cancer biology to his current role at RareCan. Listeners will gain fascinating insights into the world of basic research and the profound impact it can have on clinical practice.
You can tune in to the podcast on popular platforms such as Spotify, App, Google, or directly here.
Learn more about our Advancing Neuroendocrine Cancer Research campaign here.